[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341042-105":3,"doc-detail-341042-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","protein-tyrosine-phosphatase-prl-3-a-key-player-in-cancer-signaling","Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling","","Protein phosphatases drive signal transduction by removing phosphorylation marks from proteins, thereby shaping cellular behavior. The dual-specific phosphatase phosphatase of regenerating liver-3 (PRL-3) is implicated in cancer development, and understanding its regulatory roles is central to therapeutic progress. This review summarizes PRL-3 regulatory mechanisms—including transcriptional control, alternative splicing, and post-translational modifications—its cancer-type expression, and functional impacts on proliferation, migration, invasion, metastasis, angiogenesis, and drug resistance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/protein-tyrosine-phosphatase-prl-3-a-key-player-in-cancer-signaling/341042/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/protein-tyrosine-phosphatase-prl-3-a-key-player-in-cancer-signaling/341042.png","ImageObject",300,407,{"name":42,"@type":43},"Olivia Brown","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main biological role of protein phosphatases in signaling pathways?","Question",{"text":63,"@type":64},"Protein phosphatases primarily catalyze dephosphorylation events that modify proteins within signal transduction pathways, counterbalancing protein kinases.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is PRL-3 considered important in cancer signaling?",{"text":68,"@type":64},"PRL-3 is a dual-specific phosphatase implicated in cancer pathogenesis, contributing to processes such as proliferation, migration, invasion, metastasis, angiogenesis, and drug resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"What regulatory mechanisms control PRL-3 activity and expression?",{"text":72,"@type":64},"The review highlights transcriptional control, alternative splicing, and post-translational modifications as key regulatory mechanisms, alongside selective expression patterns across cancer types.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341042,1790221027,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd",8,"biomolecules  \nReview  \nProtein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling  \nHaidong Liu 1,2, Xiao Li 3, Yin Shi 4, Zu Ye 1,2,5,6,* and Xiangdong Cheng 1,2,5,6, *  \nCitation: Liu, H.; Li, X.; Shi, Y.; Ye, Z.;  \nCheng, X. Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling. Biomolecules 2024, 14, 342. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)biom14030342  \nAcademic Editors: Luciana Bordin and Jose R. Bayascas  \nReceived: 21 January 2024  \nRevised: 6 March 2024  \nAccepted: 8 March 2024  \nPublished: 12 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Zhejiang Cancer Hospital, Hangzhou 310022, China; [liuhd@zjcc.org.cn](liuhd@zjcc.org.cn)  \n2 Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou 310018, China  \n3 The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou 310053, China; [xiaoli@zcmu.edu.cn](xiaoli@zcmu.edu.cn)  \n4 Department of Biochemistry, Zhejiang University School of Medicine, Hangzhou 310058, China; [yinshi@zju.edu.cn](yinshi@zju.edu.cn)  \n5 Key Laboratory of Prevention, Diagnosis and Therapy of Upper Gastrointestinal Cancer of Zhejiang Province, Hangzhou 310022, China  \n6 Zhejiang Provincial Research Center for Upper Gastrointestinal Tract Cancer, Zhejiang Cancer Hospital, Hangzhou 310022, China  \n* [Correspondence: yezuqscx@zju.edu.cn](Correspondence: yezuqscx@zju.edu.cn) (Z.Y.); [chengxd@zjcc.org.cn](chengxd@zjcc.org.cn) (X.C.)  \nAbstract: Protein phosphatases are primarily responsible for dephosphorylation modification within signal transduction pathways. Phosphatase of regenerating liver-3 (PRL-3) is a dual-specific phosphatase implicated in cancer pathogenesis. Understanding PRL-3’s intricate functions and developing targeted therapies is crucial for advancing cancer treatment. This review highlights its regulatory mechanisms, expression patterns, and multifaceted roles in cancer progression. PRL-3’s involvement in proliferation, migration, invasion, metastasis, angiogenesis, and drug resistance is discussed. Regulatory mechanisms encompass transcriptional control, alternative splicing, and post-translational modifications. PRL-3 exhibits selective expressions in specific cancer types, making it a potential target for therapy. Despite advances in small molecule inhibitors, further research is needed for clinical application. PRL-3-zumab, a humanized antibody, shows promise in preclinical studies and clinical trials. Our review summarizes the current understanding of the cancer-related cellular function of PRL-3, its prognostic value, and the research progress of therapeutic inhibitors.  \nKeywords: protein phosphatases; phosphatase of regenerating liver-3 (PRL-3); cancer; drug resistance  \n1. Brief Introduction of Protein Phosphatases  \nIn the 1950s, protein phosphorylation was discovered as an important post-translational modification (PTM) that determines protein function [1] . It has a crucial function in multiple cellular activities, such as cell growth, proliferation, differentiation, migration, motility, programmed cell death, and metabolism [2] . According to estimates, phosphorylation regulates 30% of human genome-encoded proteins [3] . Protein kinases are responsible for transferring phosphate groups from ATP to substrate proteins, while protein phosphatasesplay a role in removing phosphate groups from phosphoproteins and transferring them to water molecules. Phosphatases and kinases are crucial enzymes involved in cellular signal transduction, regulating protein phosphorylation [4] .  \nBased on historical classification, protein phosphatases primarily compr","cbCaiaYjD7eUMHeu","https://ap.wps.com/l/cbCaiaYjD7eUMHeu","pdf",2421358,17,"English","# Brief Introduction of Protein Phosphatases\n## Families and classification of protein phosphatases\n## Structural features of protein tyrosine phosphatases (PTPs)\n## Conserved catalytic motifs and subfamily distinctions","[{\"question\":\"What is the main biological role of protein phosphatases in signaling pathways?\",\"answer\":\"Protein phosphatases primarily catalyze dephosphorylation events that modify proteins within signal transduction pathways, counterbalancing protein kinases.\"},{\"question\":\"Why is PRL-3 considered important in cancer signaling?\",\"answer\":\"PRL-3 is a dual-specific phosphatase implicated in cancer pathogenesis, contributing to processes such as proliferation, migration, invasion, metastasis, angiogenesis, and drug resistance.\"},{\"question\":\"What regulatory mechanisms control PRL-3 activity and expression?\",\"answer\":\"The review highlights transcriptional control, alternative splicing, and post-translational modifications as key regulatory mechanisms, alongside selective expression patterns across cancer types.\"}]","Protein Tyrosine Phosphatase PRL-3: A Key Player in Cancer Signaling | PDF",1790040080,43,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63edd624af4ed96ee4b82d85bb356819.webp",983,1390,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0127f32378fff68e1fce6a170750a0ab.webp",982,1388,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8062277bfb5d692393f40227f81995f0.webp",981,1387,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/709bc470b3de1b9db40a039bd8ad38e9.webp",980,1385,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]